Boston (1)

Primary CNS Lymphoma (1)

Refractory Primary CNS Lymphoma (1)

Relapsed Primary CNS Lymphoma (1)

Recruiting (1)

phase 1 (1)

Matthew J. Frigault, M.D. (1)

Novartis (1)

tisagenlecleucel (1)

biological (1)

Other (1)

Interventional (1)

relapsed primary cns lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jan 18, 2021